JPRN-jRCT2031210614已完成1 期
A clinical trial of STN1013600 ophthalmic solution in healthy adult male volunteer for single and repeated dose - Phase I
Migita Yukie0 个研究点目标入组 24 人开始时间: 2022年2月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old（—）
- 性别
- Male
入选标准
- •Subjects who can comply with scheduled visits, the examination and observation as specified in
- •the clinical study protocol
排除标准
- •1)Subjects have a disease and/or abnormal laboratory value which is considered inappropriate from safety evaluation perspective
- •2)Subjects who are inappropriate as participants in this study in the opinion of the investigator or sub investigator
研究者
相似试验
已完成
1 期
A phase I study of STN1013400 ophthalmic solution in healthy adult male volunteerMyopiaJPRN-jRCT2031210208Migita Yukie48
招募中
1 期
A phase I/IIa study of STN1014100 ophthalmic solution in healthy adult male volunteers and dry eye patientsDry eyeJPRN-jRCT2051220152Koji Oka134
已完成
1 期
Pharmacokinetic study of STN1012600 ophthalmic solution in healthy adult males volunteersJPRN-jRCT2051230035Koji Oka8
已完成
2 期
Study Assessing the Efficacy and Safety of STN1013600 Ophthalmic Solution 0.1% and 0.3% Compared With Placebo in Subjects With PresbyopiaPresbyopiaNCT05665387Santen Inc.79
未知
不适用
Clinical study about the ocular administration of the anti-VEGF antibody for the retinopathy of prematurityretinopathy of prematurityJPRN-UMIN000025361ara Medical University20